Advanced

The Views of European Clinicians on Guidelines for Long-Term Follow-Up of Childhood Cancer Survivors

Brown, Morven C.; Levitt, Gillian A.; Frey, Eva; Bardi, Edit; Haupt, Riccardo; Hjorth, Lars LU ; Kremer, Leontien; Kuehni, Claudia E.; Lettner, Christina and Mulder, Renee L., et al. (2015) In Pediatric Blood & Cancer 62(2). p.322-328
Abstract
Background. Evidence-based guidelines are needed to guide effective long-term follow-up (LTFU) of childhood cancer survivors (CCS) at risk of late adverse effects (LAEs). We aimed to ascertain the use of LTFU guidelines throughout Europe, and seek views on the need for pan-European LTFU guidelines. Procedures. One expert clinician from each of 44 European countries was invited to participate in an online survey. Information was sought regarding the use and content of LTFU guidelines in the respondent's centre and country, and their views about developing pan-European LTFU guidelines. Results. Thirty-one countries (70%) responded, including 24 of 26 full EU countries (92%). LTFU guidelines were implemented nationally in 17 countries (55%).... (More)
Background. Evidence-based guidelines are needed to guide effective long-term follow-up (LTFU) of childhood cancer survivors (CCS) at risk of late adverse effects (LAEs). We aimed to ascertain the use of LTFU guidelines throughout Europe, and seek views on the need for pan-European LTFU guidelines. Procedures. One expert clinician from each of 44 European countries was invited to participate in an online survey. Information was sought regarding the use and content of LTFU guidelines in the respondent's centre and country, and their views about developing pan-European LTFU guidelines. Results. Thirty-one countries (70%) responded, including 24 of 26 full EU countries (92%). LTFU guidelines were implemented nationally in 17 countries (55%). All guidelines included recommendations about physical LAEs, specific risk groups and frequency of surveillance, and the majority about psychosocial LAEs (70%), and healthy lifestyle promotion (65%). A minority of guidelines described recommendations about transition to age-appropriate LTFU services (22%), where LTFU should be performed (22%) and by whom (30%). Most respondents (94%) agreed on the need for pan-European LTFU guidelines, specifically including recommendations about surveillance for specific physical LAEs (97%), action to be taken if a specific LAE is detected (90%), minimum requirements for LTFU (93%), transition and health promotion (both 87%). Conclusions. Guidelines are not universally used throughout Europe. However, there is strong support for developing pan-European LTFU guidelines for CCS. PanCareSurFup (www.pancare.eu) will collaborate with partners to develop such guidelines, including recommendations for hitherto relatively neglected topics, such as minimum LTFU requirements, transition and health promotion. Pediatr Blood Cancer 2015;62:322-328. (C) 2014 Wiley Periodicals, Inc. (Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
adolescent, adverse effects, child, neoplasms, practice guideline, survivors
in
Pediatric Blood & Cancer
volume
62
issue
2
pages
322 - 328
publisher
John Wiley and Sons Inc.
external identifiers
  • wos:000352218600027
  • scopus:84927557117
ISSN
1545-5017
DOI
10.1002/pbc.25310
language
English
LU publication?
yes
id
c6166ccf-8904-4768-b90a-462f3de98399 (old id 5403088)
date added to LUP
2015-06-01 09:20:40
date last changed
2017-11-05 03:23:09
@article{c6166ccf-8904-4768-b90a-462f3de98399,
  abstract     = {Background. Evidence-based guidelines are needed to guide effective long-term follow-up (LTFU) of childhood cancer survivors (CCS) at risk of late adverse effects (LAEs). We aimed to ascertain the use of LTFU guidelines throughout Europe, and seek views on the need for pan-European LTFU guidelines. Procedures. One expert clinician from each of 44 European countries was invited to participate in an online survey. Information was sought regarding the use and content of LTFU guidelines in the respondent's centre and country, and their views about developing pan-European LTFU guidelines. Results. Thirty-one countries (70%) responded, including 24 of 26 full EU countries (92%). LTFU guidelines were implemented nationally in 17 countries (55%). All guidelines included recommendations about physical LAEs, specific risk groups and frequency of surveillance, and the majority about psychosocial LAEs (70%), and healthy lifestyle promotion (65%). A minority of guidelines described recommendations about transition to age-appropriate LTFU services (22%), where LTFU should be performed (22%) and by whom (30%). Most respondents (94%) agreed on the need for pan-European LTFU guidelines, specifically including recommendations about surveillance for specific physical LAEs (97%), action to be taken if a specific LAE is detected (90%), minimum requirements for LTFU (93%), transition and health promotion (both 87%). Conclusions. Guidelines are not universally used throughout Europe. However, there is strong support for developing pan-European LTFU guidelines for CCS. PanCareSurFup (www.pancare.eu) will collaborate with partners to develop such guidelines, including recommendations for hitherto relatively neglected topics, such as minimum LTFU requirements, transition and health promotion. Pediatr Blood Cancer 2015;62:322-328. (C) 2014 Wiley Periodicals, Inc.},
  author       = {Brown, Morven C. and Levitt, Gillian A. and Frey, Eva and Bardi, Edit and Haupt, Riccardo and Hjorth, Lars and Kremer, Leontien and Kuehni, Claudia E. and Lettner, Christina and Mulder, Renee L. and Michel, Gisela and Skinner, Roderick},
  issn         = {1545-5017},
  keyword      = {adolescent,adverse effects,child,neoplasms,practice guideline,survivors},
  language     = {eng},
  number       = {2},
  pages        = {322--328},
  publisher    = {John Wiley and Sons Inc.},
  series       = {Pediatric Blood & Cancer},
  title        = {The Views of European Clinicians on Guidelines for Long-Term Follow-Up of Childhood Cancer Survivors},
  url          = {http://dx.doi.org/10.1002/pbc.25310},
  volume       = {62},
  year         = {2015},
}